Adaptimmune Therapeutics drops 5% on $400 mixed shelf offering
09 April 2022 - 7:52AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adaptimmune Therapeutics (NASDAQ:ADAP)
Historical Stock Chart
From Apr 2023 to Apr 2024